Literature DB >> 4639094

Trimethoprim in human prostatic tissue and prostatic fluid.

M L Nielsen, I Hansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4639094     DOI: 10.3109/00365597209132095

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


× No keyword cloud information.
  8 in total

1.  The treatment of chronic bacterial prostatitis.

Authors:  A Pfau
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Anaerobic infections in chronic prostatitis and chronic urethritis.

Authors:  T Justesen; M L Nielsen; T Hattel
Journal:  Med Microbiol Immunol       Date:  1973-03-08       Impact factor: 3.402

3.  A comparison of oxytetracycline and trimethoprim in the treatment of Chlamydia trachomatis urethritis.

Authors:  P B Nielsen; J D Christensen; G Frentz
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

Review 4.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

Review 5.  Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.

Authors:  Andrew Chou; Elwyn Welch; Andrew Hunter; Barbara W Trautner
Journal:  Drugs       Date:  2022-03-14       Impact factor: 11.431

Review 6.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

7.  Moxalactam concentrations in human prostatic tissue.

Authors:  R P Smith; H Wilbur; N T Sutphen; A L Baltch
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 8.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.